NCT03114852

Brief Summary

The REGENT study (Familiar Renal Disease, Epidemiology and Genetics in Niteroi/Rio de Janeiro) is a epidemiological study that try to identify and clinically describe questions about genetic renal diseases in a southeast Brazilian population undergoing renal replacement therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,308

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

March 20, 2017

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 14, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 19, 2020

Completed
Last Updated

September 22, 2020

Status Verified

August 1, 2019

Enrollment Period

2.8 years

First QC Date

March 20, 2017

Last Update Submit

September 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Frequency and numbers of patients with renal familial diseases that are on renal replacement therapy in southeast Brazil.

    We will proceed a clinical interview using a questionnaire focused on the family history, among each Brazilian patients from dialysis or transplant center from the region of Niteroi/Rio de Janeiro. Patients with a positive history of familial disease will be included as a "case of familial renal disease". The results of the interviews will be analysed to create a report about incidence and prevalence of genetic renal disease among the southeast Brazilian people. At the same time we are creating a genetic reservoir to characterization of renal diseases in southeast of Brazil and we are also creating the basis to a cohort study based these families, through a new recently created outpatient unit to take care of familial renal diseases to follow all these involved renal families.

    The familial epidemiological results will be ready up to 24 months form the start of the study.

Secondary Outcomes (1)

  • Frequency of uromodulin and APOL-1 mutation in southeast Brazilian patients underwent renal replacement therapy

    From the time to DNA extraction, by using molecular studies, the DNA samples of each index cases will be analyised to uromodulin and APOL1, up to 48 months.

Study Arms (2)

CKD patients

'blood collection' Patients with chronic kidney disease in renal replacement therapy living in the sanitary administrative region of Niteroi/Rio de Janeiro. They will be interviewed about past history of familiar renal disease. They will have blood functional renal biochemistry analysed.

Diagnostic Test: blood collection

Renal Familiar Disease

'blood collection' They will have blood tested to renal genetic diseases

Diagnostic Test: blood collection

Interventions

blood collectionDIAGNOSTIC_TEST

They will have blood tested to renal genetic diseases

CKD patientsRenal Familiar Disease

Eligibility Criteria

Age12 Months - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The population to be studied will be formed by southeast Brazilians that are on renal replacement therapy as dialysis or kidney transplantation. Such patients with renal diseases will answer a questionnaire about familial involvement. Some of them will be characterized as a familial index case of not yet determined genetic kidney disease.

You may qualify if:

  • Brazilian patients underwent any type of renal replacement therapy, dialysis or kidney transplantation living in the area of Niteroi/Rio de Janeiro.
  • Relatives among the familial people of the index cases.

You may not qualify if:

  • Diabetic Nephropathy
  • Non-familial cases of known Glomerulonephritis
  • Refuse in participating of interview and blood collection to genetic tests

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Federal Fluminense

Niterói, Rio de Janeiro, 24033900, Brazil

Location

Biospecimen

Retention: SAMPLES WITH DNA

A blood collection of patients with familial history of renal disease will be done to extract DNA and to perform analysis of mutations and sequencing. After that, the samples will not be retained.

MeSH Terms

Conditions

Kidney Diseases

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Jorge R Almeida, MD, PhD

    Universidade Federal Fluminense

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 20, 2017

First Posted

April 14, 2017

Study Start

March 20, 2017

Primary Completion

December 20, 2019

Study Completion

September 19, 2020

Last Updated

September 22, 2020

Record last verified: 2019-08

Locations